-
1
Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases
Published 2021-02-01Get full text
Article -
2
-
3
-
4
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
Published 2019-06-01Get full text
Article -
5
Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
Published 2023-01-01Get full text
Article -
6
-
7
-
8
Benchmarking Safety Indicators of Surgical Treatment of Brain Metastases Combined with Intraoperative Radiotherapy: Results of Prospective Observational Study with Comparative Matc...
Published 2022-03-01“…Between November 2020 and October 2021, 35 patients were surgically treated for BM with IORT at our neuro-oncological center. Perioperative complication profiles were collected in a prospective observational cohort study by means of patient safety indicators (PSIs), hospital-acquired conditions (HACs), and specific cranial-surgery-related complications (CSCs) as high-standard quality metric tools and compared to those of an institutional cohort of 388 patients with BM resection without IORT in a balanced comparative matched-pair analysis. …”
Get full text
Article -
9
-
10
Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)
Published 2022-09-01“…All patients were treated in a large tertiary care neuro-oncological center between 2013 and 2018. Preoperative BMD was determined from the first lumbar vertebrae (L1) from routine preoperative staging computed tomography (CT) scans. …”
Get full text
Article